The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?

Author: Daud Aizati N. A.   Bergman Jorieke E. H.   Kerstjens-Frederikse Wilhelmina S.   Groen Henk   Wilffert Bob  

Publisher: MDPI

E-ISSN: 1422-0067|17|8|1333-1333

ISSN: 1422-0067

Source: International Journal of Molecular Sciences, Vol.17, Iss.8, 2016-08, pp. : 1333-1333

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content